Profiles for generic drugs starting with 'v'
✉ Email this page to a colleague
US Patents and Regulatory Information for v
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | VILAZODONE HYDROCHLORIDE | vilazodone hydrochloride | TABLET;ORAL | 208228-003 | Jul 7, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sandoz | VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 212068-001 | May 6, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET, FOR SUSPENSION;ORAL | 216157-001 | Dec 17, 2021 | DISCN | Yes | No | 9,018,210 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-001 | Nov 19, 2021 | RX | Yes | Yes | 8,198,242 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Ph Health | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-003 | Apr 15, 2020 | AP | RX | Yes | Yes | 9,974,827 | ⤷ Start Trial | ⤷ Start Trial | |||
| Heritage | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 078554-003 | Jan 9, 2009 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
